102 / 188
102
Saturday 17, October 2015
S21-9 (P)
IMPACT OF INITIATING A PRACTICE WIDE LOWER URINARY TRACT DYSFUNCTION PROGRAMME
Patrick MCKENNA
1
, Thomas W BENTLEY
2
, Glen E LEVERSON
3
and Christina J
SAUDER
4
1
University of Wisconsin School of Medicine and Public Health, Department of Urology, Division
of Pediatric Urology, Madison, USA
2
University of Wisconsin School of Medicine and Public Health, Deptartment of Urology,
Madison, USA
3
University of Wisconsin School of Medicine and Public Health, Department of Surgery,
Madison, USA
4
UW School of Medicine and Public Health, Department of Urology, Division of Pediatric
Urology, Madison, USA
S21-10 (P)
200 I/U OF BOTULINUM TOXIN IS EFFECTIVE IN THE TREATMENT OF NON-NEUROGENIC BLADDER OVERACTIVITY(OAB)Chris KIMBER
1
, Janet CHASE
2
, Deborah RECHTMAN
2
, Juan BORTAGARAY
3
and Nathalie WEBB
3
1
Monash Childrens Hospital and Monash University, Paediatric Urology, Melbourne, AUSTRALIA
2
Victorian Childrens Continence Service, Malvern, AUSTRALIA
3
Monash Children’s Hospital, Paediatric Urology, Clayton, AUSTRALIA
S21-11 (P)
PAEDIATRIC SACRAL NERVE STIMULATION; THE SOUTHAMPTON EXPERIENCEJudith DOCKRAY, Kerry WILKINSON and Henrik STEINBRECHER
University Hospitals Southampton, Paediatric Urology, Southampton, UNITED KINGDOM
09:03 -09:51
S22:
NEUROPATHIC BLADDERModerators: Raimund STEIN (Germany), Linda SHORTLIFFE (USA)
09:03 -09:06
S22-1 (PP)
★ CAN 4-HOUR VOIDING OBSERVATION DETECT NEUROGENIC BLADDER DYSFUNCTION IN NEONATES WITH ANORECTAL MALFORMATION?Helena BORG, Charlotte ARWIDSSON, Gundela HOLMDAHL and Ulla SILLÉN
Queen Silvia Children’s hospital, Department of Pediatric surgery, Gothenburg, SWEDEN
ICCS PROGRAMME SESSIONS
ESPU-N PROGRAMME SESSIONS
ESPU PROGRAMME SESSIONS
GENERAL INFO